Shield Therapeutics plc
STX.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£21,272 | -£33,293 | -£28,662 | -£19,678 |
| Dep. & Amort. | £1,115 | £1,071 | £2,332 | £2,207 |
| Deferred Tax | £0 | £0 | £0 | £1,759 |
| Stock-Based Comp. | £0 | £875 | £912 | £1,339 |
| Change in WC | £12,584 | -£7,024 | £3,186 | -£1,793 |
| Other Non-Cash | £567 | £1,245 | £3,984 | -£572 |
| Operating Cash Flow | -£7,007 | -£37,126 | -£18,247 | -£16,738 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£1,895 | -£239 | -£1,895 | -£2,064 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £0 | -£2,191 | £200 | £13 |
| Investing Cash Flow | -£1,895 | -£2,430 | -£1,695 | -£2,051 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £4,461 | £23,998 | £9,080 | £0 |
| Stock Issued | -£87 | £26,817 | £87 | £37,392 |
| Stock Repurch. | £0 | £0 | -£82 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£167 | -£1,159 | -£1,378 | -£9,808 |
| Financing Cash Flow | £4,207 | £49,656 | £7,707 | £27,584 |
| Forex Effect | -£639 | £446 | £2,939 | £382 |
| Net Chg. in Cash | -£5,333 | £10,546 | -£9,296 | £9,177 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £10,941 | £3,402 | £12,117 | £2,940 |
| End Cash | £5,608 | £13,948 | £2,821 | £12,117 |
| Free Cash Flow | -£7,034 | -£40,074 | -£20,142 | -£18,802 |